R

Rocket Pharmaceuticals
D

RCKT

2.20500
USD
-0.11
(-4.55%)
مغلق
حجم التداول
109,363
الربح لكل سهم
-0
العائد الربحي
-
P/E
-13
حجم السوق
242,052,986
أصول ذات صلة

العنوان: Rocket Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.